Employers face rising costs and coverage decisions on glp-1 drugs Brian Orsinger, CEBS, GBDS, VBS, Contributing Writer 25, 2026// Summary: Glp-1 drugs cost over $1,000 per month per patient McConkey Insurance & Benefits advises on employer coverage strategies Demand for glp-1 medications growing rapidly among employees A few years ago, GLP-1 medications were primarily known as treatments for type 2 diabetes
To put that in perspective, a person weighing 200 pounds might lose around 30 pounds
Published Research Data Quantified findings from peer-reviewed studies on Melanotan 2 amino acid residues in the Melanotan-2 cyclic peptide sequence melanocortin receptor subtypes (MC1RMC5R) with documented binding affinity HPLC-verified purity range across published batch testing Published Research Studies on Melanotan 2 2006 The melanocortin peptides and their receptors: relevance to Melanotan-2 research Peptides Review of melanocortin peptide pharmacology and the receptor binding profile of Melanotan-2 across MC1RMC5R subtypes
When tested in patients with type 2 diabetes, Efendic had noticed that they lost more weight than when just on insulin (Phelan
Its also possible that another underlying condition, perhaps a less common one, could play a role